Berenberg Bank Reaffirms “Buy” Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reaffirmed by equities research analysts at Berenberg Bank in a research report issued on Wednesday, Marketbeat Ratings reports. They presently have a GBX 300 ($3.90) price target on the stock. Berenberg Bank’s price target indicates a potential upside of 45.29% from the stock’s previous close.

Advanced Medical Solutions Group Stock Performance

Shares of Advanced Medical Solutions Group stock opened at GBX 206.48 ($2.68) on Wednesday. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The company has a market cap of £445.84 million, a PE ratio of 40.01, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The business has a 50 day moving average price of GBX 211.07 and a 200-day moving average price of GBX 213.11. Advanced Medical Solutions Group has a 52 week low of GBX 176.60 ($2.30) and a 52 week high of GBX 275.83 ($3.59).

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.